Special Issue: Molecular Mechanisms of Schizophrenia

Biological Psychiatry

Volumn 60, Issue 6, 2006, Pages 527-529

  Friedman, Joseph I ^a   Davis, Kenneth L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

BRAIN DYSFUNCTION; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; EDITORIAL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

HUMANS; SCHIZOPHRENIA;

EID: 33748746247     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.08.010     Document Type: Editorial

References (19)

1. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 (1991) 1474-1476
2. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
3. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12 (2006) 824-828
4. Yurek D.M., Zhang L., Fletcher-Turner A., and Seroogy K.B. Supranigral injection of neuregulin1-beta induces striatal dopamine overflow. Brain Res 1028 (2004) 116-119
5. Jentsch J.D., Tran A., Le D., Youngren K.D., and Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17 (1997) 92-99
6. Konradsson A., Marcus M.M., Hertel P., Svensson T.H., and Jardemark K.E. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex. Synapse 60 (2006) 102-108
7. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 102 (2005) 8627-8632
8. Glahn D.C., Therman S., Manninen M., Huttunen M., Kaprio J., Lonnqvist J., and Cannon T.D. Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 53 (2003) 624-626
9. Cannon T.D., Thompson P.M., van Erp T.G., Toga A.W., Poutanen V.P., Huttunen M., et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci USA 99 (2002) 3228-3233
10. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 59 (2002) 1085-1096
11. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., et al. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 60 (2006) 548-553
12. Hajszan T., Leranth C., and Roth R.H. Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol Psychiatry 60 (2006) 639-644
13. Lane H.-Y., Huang C.-L., Wu P.-L., Liu Y.-C., Chang Y.-C., Lin P.-Y., et al. Glycine transporter I inhibitor, n-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biol Psychiatry 60 (2006) 645-649
14. Tseng K.Y., Amin F., Lewis B.L., and O'Donnell P. Altered prefrontal cortical metabolic response to mesocortical activation in adult animals with a neonatal ventral hippocampal lesion. Biol Psychiatry 60 (2006) 585-590
15. Gilbert F., Morissette M., St-Hilaire M., Paquet B., Rouillard C., Di Paolo T., and Lev́esque D. Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry 60 (2006) 538-547
16. Liu Y.-L., Fann C.S.-J., Liu C.-M., Chen W.J., Wu J.-Y., Hung S.-I., et al. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol Psychiatry 60 (2006) 554-562
17. Winterer G., Egan M.F., Kolachana B.S., Goldberg T.E., Coppola R., and Weinberger D.R. Prefrontal electrophysiologic "noise" and catechol-o-methyltransferase genotype in schizophrenia. Biol Psychiatry 60 (2006) 578-584
18. Ahveninen J., Jääskeläinen I.P., Osipova D., Huttunen M.O., Ilmoniemi R.J., Kaprio J., et al. Inherited auditory-cortical dysfunction in twin pairs discordant for schizophrenia. Biol Psychiatry 60 (2006) 612-620
19. Schubert M.H., Young K.A., and Hicks P.B. Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychiatry 60 (2006) 529-532